HBLTX
Price
$14.37
Change
-$0.21 (-1.44%)
Updated
Dec 18 closing price
VWIAX
Price
$59.78
Change
-$3.22 (-5.11%)
Updated
Dec 18 closing price
Ad is loading...

HBLTX vs VWIAX

Header iconHBLTX vs VWIAX Comparison
Open Charts HBLTX vs VWIAXBanner chart's image
Hartford Balanced Income R5
Price$14.37
Change-$0.21 (-1.44%)
VolumeN/A
CapitalizationN/A
Vanguard Wellesley® Income Admiral™
Price$59.78
Change-$3.22 (-5.11%)
VolumeN/A
CapitalizationN/A
HBLTX vs VWIAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
HBLTX vs. VWIAX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HBLTX is a Hold and VWIAX is a Hold.

FUNDAMENTALS
Fundamentals
VWIAX has more cash in the bank: 51.3B vs. HBLTX (11.8B). HBLTX (3.54) and VWIAX (3.45) have matching dividends . HBLTX was incepted earlier than VWIAX: HBLTX (15 years) vs VWIAX (24 years). HBLTX is a more actively managed with annual turnover of: 57.00 vs. VWIAX (53.00). HBLTX has a lower initial minimum investment than VWIAX: HBLTX (0) vs VWIAX (50000). HBLTX annual gain was more profitable for investors over the last year : 9.10 vs. VWIAX (7.16). HBLTX return over 5 years is better than : 15.08 vs. VWIAX (4.62).
HBLTXVWIAXHBLTX / VWIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence15 years24 years-
Gain YTD7.9126.202128%
Front LoadN/AN/A-
Min. Initial Investment050000-
Min. Initial Investment IRAN/AN/A-
Net Assets11.8B51.3B23%
Annual Yield % from dividends3.543.45103%
Returns for 1 year9.107.16127%
Returns for 3 years4.50-7.39-61%
Returns for 5 years15.084.62326%
Returns for 10 years40.9722.46182%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VFF0.800.03
+3.86%
Village Farms International
ADIL1.130.03
+3.20%
Adial Pharmaceuticals
RKLB26.370.47
+1.81%
Rocket Lab USA
KYMR42.30-0.76
-1.76%
Kymera Therapeutics
EGBN28.61-0.84
-2.85%
Eagle Bancorp